SCHEMBL21532573

SCHEMBL21532573

c1ccc(-c2nnc(-c3ccccc3)n2-c2cccc3c2c2ccccc2n3-c2cccc(-c3ccccc3-c3cccc(-n4c5ccccc5c5c6oc7ccccc7c6ccc54)c3)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.35
AKT1 P31749 2/20 0.33
PRKDC P78527 1/20 0.33
ALDH1A1 P00352 2/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32
BRCA1 P38398 1/20 0.32
KMT2A Q03164 1/20 0.32
HSD17B10 Q99714 1/20 0.32
GGPS1 O95749 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
HIF1A Q16665 1/20 0.31
LMNA P02545 1/20 0.30
PPARG P37231 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
NR2E3 Q9Y5X4 1/20 0.30
NCOR2 Q9Y618 1/20 0.30
PRMT5 O14744 1/20 0.30
WDR77 Q9BQA1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532245 0.97 ALOX5 (0.34) ALOX5AKT1PRKDCALDH1A1MEN1
SCHEMBL23911751 0.97 ALOX5 (0.34) ALOX5AKT1PRKDCALDH1A1MEN1
SCHEMBL21532579 0.96 ALOX5 (0.35) ALOX5AKT1PRKDCALDH1A1MEN1
SCHEMBL21532368 0.96 ALOX5 (0.33) ALOX5AKT1PRKDCALDH1A1MEN1
SCHEMBL21532524 0.95 ALOX5 (0.33) ALOX5AKT1PRKDCALDH1A1MEN1
SCHEMBL21532279 0.95 ALDH1A1 (0.34) AKT1ALDH1A1MEN1POLBTSHR
SCHEMBL21532303 0.94 ALDH1A1 (0.33) AKT1ALDH1A1MEN1POLBTSHR
SCHEMBL21532609 0.94 ALDH1A1 (0.34) ALOX5AKT1ALDH1A1MEN1POLB
SCHEMBL21532403 0.93 ALOX5 (0.33) ALOX5AKT1PRKDCALDH1A1MEN1
SCHEMBL21532520 0.92 ALOX5 (0.36) ALOX5AKT1PRKDCALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 ALOX5 3170/4885AKT1 2105/4885PRKDC 4851/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 ALOX5 2800/4885AKT1 2483/4885PRKDC 4874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.